登士柏西诺德(XRAY)
搜索文档
Dentsply Sirona to Host First Quarter Conference Call on May 2nd
Newsfilter· 2024-04-10 04:30
CHARLOTTE, N.C., April 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, May 2, 2024, at 8:30 am ET to review its first quarter financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information A live webcast will be ava ...
Here's Why Dentsply International (XRAY) is a Strong Value Stock
Zacks Investment Research· 2024-04-04 22:45
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium includes access to the Zacks Style Scores as well.What are the Zacks Style Scores?D ...
Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio Now
Zacks Investment Research· 2024-04-02 22:46
公司概况 - DENTSPLY SIRONA (XRAY)因产品组合强大和持续专注于研发而为增长做好准备[1] - 公司市值达到68.8亿美元,是全球牙科耗材、牙科实验室产品、牙科专业产品和可消耗医疗器械产品设计、开发、制造和营销的领导者[2] 产品和解决方案 - Byte和SureSmile的持续需求是DENTSPLY SIRONA正畸和种植解决方案销售的关键驱动力[3] - XRAY推出了Lucitone for Primeprint,有望加速牙科诊所中3D打印的应用[6] 财务表现和展望 - XRAY正在从早期的转型活动中受益,包括减少人员、简化管理结构、集中职能和基础设施优化,这些举措为公司带来了显著的成本节约,从而提升了2024年的盈利前景[5] - Zacks对2024年营收的共识估计为399亿美元,比2023年水平增长了0.7%[10] - 2024年调整后的每股盈利预期为2.06美元,同比增长12.5%[11] 市场挑战和趋势 - DENTSPLY SIRONA在许多地区面临宏观经济逆风,尤其是在非美国市场[7] - Connected Technology Solutions在第四季度的销售受到成像软件的影响,这一趋势可能在今年继续影响该部门[8] - 上一季度设备、仪器和种植物的销售下降,引发了担忧[9]
Here's Why Dentsply International (XRAY) is a Strong Momentum Stock
Zacks Investment Research· 2024-03-21 23:11
Zacks Premium - Zacks Premium提供多种方式帮助投资者更聪明、更自信地投资[1] Zacks Style Scores - Zacks Style Scores是与Zacks Rank一起开发的,根据价值、增长和动量特征对股票进行评级[3] VGM Score - VGM Score是所有Style Scores的组合,是最全面的指标之一,帮助筛选具有最具吸引力价值、最佳增长预测和最有前景动量的公司[8] 投资策略 - 通过结合Zacks Rank和Style Scores,投资者可以选择具有最高成功概率的股票[12] Dentsply International (XRAY) - Dentsply International (XRAY)是一家总部位于宾夕法尼亚州约克市的公司,是全球领先的牙科耗材、牙科实验室产品、牙科专业产品和可消耗医疗器械产品的设计、开发、制造和营销商[15] - XRAY在Zacks Rank上为3(持有),VGM Score为A,具有良好的动量风格评分[15] - XRAY在过去四周股价上涨了0.7%,具有良好的动量风格评分[16] - 在2024财年,五位分析师在过去60天内上调了他们的盈利预期,Zacks Consensus Estimate已增加至每股2.05美元,XRAY的平均盈利惊喜率为10.3%[17] - XRAY具有坚实的Zacks Rank和顶级的动量和VGM风格评分,应该被列入投资者的备选名单[18]
Why Dentsply International (XRAY) is a Top Value Stock for the Long-Term
Zacks Investment Research· 2024-03-19 22:41
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium also includes the Zacks Style Scores.What are the Zacks Style Scores?The Zacks ...
DENTSPLY SIRONA(XRAY) - 2023 Q4 - Earnings Call Presentation
2024-03-01 00:01
Fourth Quarter 2023 Earnings Conference Call February 29, 2024 Forward-Looking Statements and Associated Risks This presentation contains statements that do not directly and exclusively relate to historical facts which constitute forward-looking statements, including, statements and projections concerning, among other things, the expected timing, benefits and costs associated with the Company's restructuring plan described in this presentation. The Company's forward-looking statements represent current expe ...
DENTSPLY SIRONA(XRAY) - 2023 Q4 - Earnings Call Transcript
2024-02-29 23:46
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Q4 2023 Earnings Conference Call February 29, 2024 8:30 AM ET Company Participants Andrea Daley - Vice President-Investor Relations Simon Campion - Chief Executive Officer Glenn Coleman - Chief Financial Officer Andreas Frank - Executive Vice President & Chief Business Officer Conference Call Participants Nathan Rich - Goldman Sachs Michael Cherny - Leerink Partners Elizabeth Anderson - Evercore ISI Jon Block - Stifel Michael Cherny - Leerink Partners Jeff Johnson - Baird ...
Dentsply (XRAY) Reports Q4 Earnings: What Key Metrics Have to Say
Zacks Investment Research· 2024-02-29 23:36
营收情况 - Dentsply International (XRAY)在2023年12月结束的季度报告显示,营收为10.1亿美元,同比增长3%[1] - 公司的营收超出了Zacks Consensus Estimate的968.43亿美元,意味着有4.50%的惊喜[2] - 有机销售增长为1.9%,高于六位分析师平均预期的-3.1%[5] 每股收益 - 每股收益为0.44美元,较去年同期的0.46美元有所下降[1] - 每股收益也超出了预期,达到了0.43美元的共识预期[2] 地区营收表现 - 美国营收为3.68亿美元,高于三位分析师平均预期的3.59亿美元[5] - 其他地区营收为2.47亿美元,高于三位分析师平均预期的2.25亿美元[5] - 欧洲营收为3.97亿美元,高于三位分析师平均预期的3.81亿美元[6] 股票表现 - Dentsply的股票在过去一个月中表现不佳,下跌了4.2%,而Zacks S&P 500综合指数上涨了3.9%[11] - 公司目前的Zacks排名为3(持有),表明其在短期内可能与整体市场表现一致[11]
DENTSPLY SIRONA (XRAY) Q4 Earnings Beat Estimates, Sales Up Y/Y
Zacks Investment Research· 2024-02-29 22:51
DENTSPLY SIRONA Inc. (XRAY) reported fourth-quarter 2023 adjusted earnings per share (EPS) of 44 cents, which beat the Zacks Consensus Estimate of 43 cents by 2.3%. However, the bottom line declined 4% on a year-over-year basis.On a GAAP basis, the company reported an EPS of 32 cents against a reported loss of 7 cents per share in the year-ago quarter.RevenuesRevenues in the reported quarter totaled $1.01 billion, which beat the Zacks Consensus Estimate by 4.5%. The top line also rose 2.9% year over year an ...
Dentsply International (XRAY) Q4 Earnings and Revenues Beat Estimates
Zacks Investment Research· 2024-02-29 21:11
Dentsply International (XRAY) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.46 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 2.33%. A quarter ago, it was expected that this dental products manufacturer would post earnings of $0.48 per share when it actually produced earnings of $0.49, delivering a surprise of 2.08%.Over the last f ...